SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-23-022022
Filing Date
2023-12-06
Accepted
2023-12-06 16:06:26
Documents
2
Period of Report
2023-12-04

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 1590
2 EXHIBIT 24 exhibit24.htm EX-24 471117
  Complete submission text file 0001062993-23-022022.txt   474157
Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Issuer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CENTURY THERAPEUTICS, INC. 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address
Pfeiffenberger Brent (Reporting) CIK: 0002001162 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40498 | Film No.: 231469670